Bristol-Myers Squibb
BMY
BMY
2,210 hedge funds and large institutions have $100B invested in Bristol-Myers Squibb in 2020 Q3 according to their latest regulatory filings, with 136 funds opening new positions, 888 increasing their positions, 910 reducing their positions, and 91 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
2% less repeat investments, than reductions
Existing positions increased: 888 | Existing positions reduced: 910
9% less call options, than puts
Call options by funds: $1.25B | Put options by funds: $1.38B
15% less funds holding in top 10
Funds holding in top 10: 110 → 93 (-17)
Holders
2,210
Holding in Top 10
93
Calls
$1.25B
Puts
$1.38B
Top Buyers
| 1 | +$1.81B | |
| 2 | +$192M | |
| 3 | +$154M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$134M |
| 5 |
Bessemer Group
Woodbridge,
New Jersey
|
+$132M |
Top Sellers
| 1 | -$779M | |
| 2 | -$583M | |
| 3 | -$470M | |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$382M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$230M |